Table 1. Patient characteristics of 25 study participants.
Patient | ICU cohort | Age/ Gender |
BI before ICU | Sepsis condition |
Sepsis focus | APACHE-II/ Worst SOFA |
Ventilation (days) |
---|---|---|---|---|---|---|---|
1 | Sepsis | 63/F | 100 | Shock | Abdomen | 20/18 | 72 |
2 | Sepsis | 82/F | 90 | Shock | Urogenital | 29/15 | 12 |
3 | Sepsis | 85/F | 95 | Severe Sepsis | Abdomen | 14/16 | 0 |
4 | Sepsis | 73/M | 100 | Shock | Abdomen | 42/15 | 20 |
5 | Sepsis | 57/M | 100 | Shock | Abdomen | 27/11 | 2 |
6 | Sepsis | 55/M | 100 | Shock | Abdomen | 12/6 | 0 |
7 | Sepsis | 80/F | 95 | Shock | Urogenital | 24/12 | 2 |
8 | Sepsis | 64/M | 100 | Shock | Soft tissue | 11/14 | 27 |
9 | Sepsis | 72/F | 35 | Shock | Urogenital | 9/4 | 0 |
10 | Sepsis | 44/M | 95 | Shock | Abdomen | 40/8 | 10 |
11 | Sepsis | 76/F | 100 | Shock | Pulmo | 39/12 | 16 |
12 | Sepsis | 74/F | 90 | Shock | Pulmo | 23/13 | 9 |
13 | Sepsis | 72/F | 100 | Shock | Urogenital | 38/10 | 0 |
14 | Sepsis | 75/M | 100 | Severe Sepsis | Urogenital | 37/10 | 2 |
15 | Sepsis | 79/F | 100 | Shock | Soft tissue | 22/6 | 1 |
16 | Sepsis | 32/M | 100 | Shock | Abdomen | 19/9 | 4 |
17 | Sepsis | 54/F | 100 | Shock | Soft tissue | 48/11 | 8 |
18 | Sepsis | 55/F | 75 | Shock | Soft tissue | 39/14 | 6 |
19 | Sepsis | 60/F | 70 | Shock | Soft tissue | 23/12 | 12 |
20 | Sepsis | 81/M | 100 | Shock | Urogenital | 38/12 | 20 |
21 | Control | 74/M | 100 | None | n.a. | 23/3 | 1 |
22 | Control | 63/M | 100 | None | n.a. | 9/5 | 0 |
23 | Control | 18/F | 100 | None | n.a. | 14/5 | 1 |
24 | Control | 74/M | 100 | SIRS | n.a. | 17/5 | 0 |
25 | Control | 77/F | 100 | SIRS | n.a. | 22/7 | 1 |
APACHE-II Acute physiology and chronic health evaluation score, BI Barthel index (activities of daily living), F Female, ICU Intensive care unit, M Male, n.a. Not applicable, SIRS Systemic inflammatory response syndrome, SOFA Sepsis-related organ failure assessment score.